Clinical Trials
14 trialsNCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT05842031 2026-03-04
Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer
M.D. Anderson Cancer Center
Suspended
NCT04923178 2026-01-26
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05264337 2026-01-16
Lymphedema After Urologic Surgery
Vastra Gotaland Region
Recruiting
NCT04996849 2025-09-24
Contemporary Characteristics of Penile Cancer
M.D. Anderson Cancer Center
Terminated
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT06565585 2024-08-23
Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell Carcinoma
Universitaire Ziekenhuizen KU Leuven
Enrolling by invitation
NCT05447273 2024-04-03
The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma
Oslo University Hospital
Recruiting
NCT05671263 2023-01-09
Genital Lichen Sclerosus - Epidemiology, Comorbidities and the Role of Vulvar and Penile Microbiome
Region Jönköping County
Unknown
NCT04574427 2022-10-19
INFLUENCE
The Netherlands Cancer Institute
Completed
NCT01236053 2017-07-06
Cancer in Patients With Gabapentin (GPRD)
GlaxoSmithKline
Completed
NCT00900302 2016-02-10
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Completed